A new partnership between virtual ward start-up Doccla, wearable tech company AliveCor, and a UK healthcare trust will examine the care of patients with
GSK's severe asthma therapy Nucala could find a new lease of life as a treatment for chronic obstructive pulmonary disease (COPD) after showing a clear benefit in a phase 3 trial.<